GB9501308D0 - Aqueous-based formulations for enteric coated products - Google Patents

Aqueous-based formulations for enteric coated products

Info

Publication number
GB9501308D0
GB9501308D0 GBGB9501308.2A GB9501308A GB9501308D0 GB 9501308 D0 GB9501308 D0 GB 9501308D0 GB 9501308 A GB9501308 A GB 9501308A GB 9501308 D0 GB9501308 D0 GB 9501308D0
Authority
GB
United Kingdom
Prior art keywords
aqueous
enteric coated
based formulations
coated products
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9501308.2A
Other versions
GB2285989A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Frosst Canada and Co
Original Assignee
Merck Frosst Canada and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada and Co filed Critical Merck Frosst Canada and Co
Publication of GB9501308D0 publication Critical patent/GB9501308D0/en
Publication of GB2285989A publication Critical patent/GB2285989A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
GB9501308A 1994-01-28 1995-01-24 Aqueous formulations for enteric coatings Withdrawn GB2285989A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18854694A 1994-01-28 1994-01-28

Publications (2)

Publication Number Publication Date
GB9501308D0 true GB9501308D0 (en) 1995-03-15
GB2285989A GB2285989A (en) 1995-08-02

Family

ID=22693612

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9501308A Withdrawn GB2285989A (en) 1994-01-28 1995-01-24 Aqueous formulations for enteric coatings

Country Status (1)

Country Link
GB (1) GB2285989A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE414509T1 (en) * 1994-07-08 2008-12-15 Astrazeneca Ab TABLETED DOSE FORM COMPOSED OF MANY INDIVIDUAL UNITS
SE9500422D0 (en) * 1995-02-06 1995-02-06 Astra Ab New oral pharmaceutical dosage forms
SE512835C2 (en) * 1996-01-08 2000-05-22 Astrazeneca Ab Dosage form containing a plurality of units all containing acid labile H + K + ATPase inhibitors
SE9600071D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
SE9600070D0 (en) 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9600072D0 (en) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
GB0518579D0 (en) * 2005-09-12 2005-10-19 Cr Technologies Llp Controlled delivery creatine formulations and method of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL121337C (en) * 1961-09-25
US3629237A (en) * 1968-09-12 1971-12-21 Shinetsu Chemical Co Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them
US4088798A (en) * 1975-11-11 1978-05-09 Sandoz, Inc. Methods for the preparation of controlled gastric residence time medicament formulations
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
JPS5855125B2 (en) * 1980-03-10 1983-12-08 信越化学工業株式会社 Enteric coating agent composition for solid drugs
EP0164669B1 (en) * 1984-06-13 1991-01-23 Röhm Gmbh Process for coating pharmaceutical forms
US4880636A (en) * 1988-05-13 1989-11-14 Franz Robert M Film coated tablet of ranitidine HCl

Also Published As

Publication number Publication date
GB2285989A (en) 1995-08-02

Similar Documents

Publication Publication Date Title
EP0688557A3 (en) Hairspray compositions
ZA95776B (en) Novel formulation
AP9901495A0 (en) Aqueous-based pharmaceutical composition
GB2296714B (en) Coating composition
GB9415239D0 (en) Coating compositions
GB9501308D0 (en) Aqueous-based formulations for enteric coated products
ZA951426B (en) Lysine products
GB2289471B (en) Coating compositions
GB2287943B (en) Coating composition
GB2301109B (en) Coating composition
HK1010388A1 (en) Paint formulations
GB9420612D0 (en) Coating compositions
GB9500689D0 (en) Aerosol composition
GB2289896B (en) Coating composition
ZA973116B (en) Enteric coated pharmaceutical composition
GB9404989D0 (en) Lipomimetric formulation
ZA988733B (en) Coated products
GB9416034D0 (en) Novel formulation
GB9412520D0 (en) Novel formulation
GB9412519D0 (en) Novel formulation
GB9402046D0 (en) Novel formulation
GB9409999D0 (en) Coating compositions
GB9410118D0 (en) Coating compositions
GB9417509D0 (en) Coating compositions
ZA952725B (en) Coating compositions

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)